Hong Kong SAR

David Morton, the former head of corporates, financials and multinational banking (CFMB) at HSBC, has announced his retirement.

China’s Frontage Holdings Corp, which provides support to pharmaceutical companies, has refiled a draft IPO prospectus with Hong Kong’s stock exchange.

GLP has closed a Rmb3.3bn ($490m) nine year Panda bond, after scrapping an earlier plan to sell a dual-tranche deal.

Hong Kong Exchanges and Clearing (HKEX) will launch futures contracts on the A-share segment of the MSCI China Index.

Shanghai Fudan-Zhangjian Bio-Pharmaceutical Co has become the first Hong Kong-listed company to announce that it wants to float on China’s hotly-anticipated technology board.

Hong Kong Exchanges and Clearing (HKEX) signed an agreement with MSCI on Monday to introduce a futures contract covering the MSCI China shares index.

China-based biotechnology firm Mabpharm is looking for the greenlight to list in Hong Kong, having filed a draft IPO prospectus with the city’s stock exchange.

Solar glass manufacturer Xinyi Solar Holdings has raised HK$1.32bn ($168m) after selling a block of new shares in a top-up placement.

In his latest Clawback column, Philippe Espinasse takes a look at the Hong Kong stock exchange’s new three year plan and its desire to be a global listing hub.

Link Real Estate Investment Trust has pulled off a record-breaking equity-linked deal, issuing the first green convertible notes in Asia Pacific, according to a source close to the transaction.

Futu Holdings, the parent of Hong Kong-based Futu Securities, has pulled off the first IPO by a Chinese online brokerage. The company was on track to raise $160m on Thursday after making a late change to the deal, cutting the size of its float and adding a private placement to an international fund. Jonathan Breen reports.

Xinyi Group (Glass) Co has launched a block trade of Xinyi Solar Holdings shares,. The company is looking to raise up to HK$1.35bn ($172.3m), according to a term sheet seen by GlobalCapital Asia.